Vivos Therapeutics, Inc.VVOSNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank50
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P50
Within normal range
vs 5Y Ago
-0.3x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2024-4.00%
202337.84%
2022-13.13%
2021-212.57%
2020-5.16%
201915.97%
20180.00%